Depuis octobre 2024, la stérilisation centrale des HCL située à Saint-Priest recrute ses agents par simulation, sans présentation de cv ou entretien nécessaire.

Cingulate Inc. a annoncé que les données issues de son principal candidat contre le trouble du déficit de l'attention avec ou sans hyperactivité (TDAH), le CTx-1301 (chlorhydrate de dexméthylphénidate ...

- Results from the BL-B01D1-303 (NCT06118333) phase III trial presented in a late-breaking oral presentation at ESMO represents the first data readout for iza-bren from a registration enabling study ...

Le budget 2026 sera celui du Parlement. L’examen du budget commence lundi 20 octobre en commission à l’Assemblée. De nombreuses mesures – dont l’augmentation du prix du litre de E85 – seront remises ...

Presenting Author: Aftab Ala, MBBS, M.D., FRCP, Ph.D. The abstract is currently available on the conference website, and the materials for the oral presentation will be available at www.monopartx.com ...

BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics today announced that new clinical data on HLD-0915, the company’s first-in-class oral RIPTAC™ therapeutic, will be presented at the plenary ...

Despite being common pathological entities found in the oral cavity, oral mucoceles can present distinct features, raising several diagnostic possibilities and treatments. In this study, we report the ...

CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Neutrolis Inc., a clinical-stage biotech company focused on targeting Neutrophil Extracellular Traps (NETs) to revolutionize the treatment of ...

The data will also be featured in a poster presentation the same day during Poster Session B between 12:30 – 4:00 p.m. ET, Level 2, Exhibit Hall D.

SAN DIEGO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that ...

RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, ...